Federal Register Notice for Rulemaking

The proposed rule to mandate the use of MedDRA has been published in the Federal Register for comment.

Companies can license MedDRA from an international maintenance and support services organization (MSSO) (toll free number 877.258.8280, fax 703.345.7791, e-mail mssosubscribe@ngc.com, Internet at www.meddramsso.com.

The document mentioned above may be found on the FDA Web site.